INDOSYL MONO is indicated for: The treatment of hypertension;,INDOSYL MONO is indicated for: the treatment of heart failure. In such patients it is recommended that INDOSYL MONO be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of INDOSYL MONO has not been demonstrated for New York Heart Association Category IV patients),INDOSYL MONO is indicated for: Patients with established coronary artery disease (See Clinical Trials) who are stable on concomitant therapy and have no heart failure to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Store in a Dry Place
Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A green, round, biconvex, uncoated tablet engraved with an open heart symbol on one face and the Servier logo on the other face.
Images are the copyright of Medicines Information Pty Ltd
We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
INDOSYL MONO is indicated for: The treatment of hypertension;,INDOSYL MONO is indicated for: the treatment of heart failure. In such patients it is recommended that INDOSYL MONO be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of INDOSYL MONO has not been demonstrated for New York Heart Association Category IV patients),INDOSYL MONO is indicated for: Patients with established coronary artery disease (See Clinical Trials) who are stable on concomitant therapy and have no heart failure to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Store in a Dry Place
Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A white round biconvex uncoated tablet, 5mm in diameter and 2.45mm in depth.
Images are the copyright of Medicines Information Pty Ltd
We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
INDOSYL MONO is indicated for: The treatment of hypertension;,INDOSYL MONO is indicated for: the treatment of heart failure. In such patients it is recommended that INDOSYL MONO be given with a diuretic and/or digoxin under close medical supervision. (The safety and efficacy of INDOSYL MONO has not been demonstrated for New York Heart Association Category IV patients),INDOSYL MONO is indicated for: Patients with established coronary artery disease (See Clinical Trials) who are stable on concomitant therapy and have no heart failure to reduce the risk of non-fatal myocardial infarction or cardiac arrest.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 30 degrees Celsius
Store in a Dry Place
Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A white elongated rod shaped biconvex uncoated tablet with rounded ends, being 8mm long, 4mm in width and 2.75mm in depth with a breakline scored on both faces.
Images are the copyright of Medicines Information Pty Ltd
We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.